Spring Works Therapeutics (SWTX) PT Raised to $123 at Goldman Sachs, Following Business Update

July 20, 2021 11:39 AM EDT
Get Alerts SWTX Hot Sheet
Price: $68.70 -2.35%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 5 | New: 36
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Goldman Sachs analyst Corinne Jenkins raised the price target on Spring Works Therapeutics (NASDAQ: SWTX) to $123.00 (from $107.00) while maintaining a Buy rating.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

Goldman Sachs